President Donald Trump has signed an executive order directing federal agencies to streamline the review process for certain experimental therapies being studied for mental health conditions.
The initiative focuses on treatments that have already received special regulatory designations intended to support the development of promising medical therapies. Administration officials say the goal is to reduce unnecessary delays while maintaining scientific and safety standards.
Continue reading on next page…